Professor Ernest Choy is joined by Dr James Galloway and Dr Andra Negoescu to discuss the importance of immunisation in patients with RA, with a focus on COVID-19 vaccination. Together they examine the evidence on the effectiveness and safety of COVID-19 vaccination in RA patients and review the latest ACR and EULAR guidance on the use of the COVID-19 vaccine. Concluding the webinar is a 25-minute panel discussion where the faculty members share their experience on how to support patients through the vaccination process.
Inflammation Xchange is a medical education programme dedicated to UK rheumatologists that strives to optimise RA services to deliver the best possible patient care through sharing best practice and discussing complex cases within the RA treatment landscape.
Job Code: UK-RA-NA-202110-00015
Date of preparation: March 2022
James Galloway
Reader and Honorary Consultant Rheumatologist, King's College London
Dr Galloway is a clinical lecturer at King's College London and an honorary consultant in rheumatology at King's College Hospital. He runs the biologics assessment service for the rheumatology department and has specialist interests in the areas of inflammatory arthritis and biologic therapy, and also in sarcoidosis. His research group works on areas including pharmacovigilance, health outcomes and quality improvement in the field of rheumatology. Within his role for KCL he works in the CRC accredited King's Clinical Trials Unit.
Ernest Choy
Head of Rheumatology and Translational Research, Cardiff University School of Medicine
Prof Ernest Choy is Head of Rheumatology and Translational Research at the Institute of Infection and Immunity as well as the Director of the Cardiff Regional Experimental Arthritis Treatment and Evaluation Centre at Cardiff University School of Medicine. He is also an Honorary Consultant Rheumatologist at University Hospital of Wales and Clinical Lead of the Welsh Arthritis Research Network.
Andra Negoescu
Cambridge University NHS Foundation Trust
Consultant Rheumatologist and EIA Lead
Dr. Andra Negoescu is a Consultant Rheumatologist at Addenbrooke’s Hospital in Cambridge. She qualified in Bucharest, Romania, where she started her training in Rheumatology. She has an interest in (early) rheumatoid arthritis, adolescent Rheumatology, biologic therapies, Methotrexate safety and tolerability, and musculoskeletal ultrasound.
Watch our webinar Understanding the moderate RA patient journey with Professor Philip Conaghan, Professor Chris Edwards and Dr Marwan Bukhari
Watch this space for the recordings of our 2022 Inflammation Xchange Meeting focused on personalised patient care!
UK-RA-NA-202202-00014 | Date of preparation March 2023
Adverse events should be reported.
For Great Britain, reporting forms and information can be found at yellowcard.mhra.gov.uk or via the Yellow Card app (download from the Apple App Store or Google Play Store).
Adverse events should also be reported to Galapagos via email to DrugSafety.UK.Ireland@glpg.com or 0800 072 7878.
Adverse events should be reported.
For Northern Ireland, reporting forms and information can be found at yellowcard.mhra.gov.uk or via the Yellow Card app (download from the Apple App Store or Google Play Store).
Adverse events should also be reported to Galapagos via email to DrugSafety.UK.Ireland@glpg.com or 0800 072 7878.
Adverse events should be reported.
For the Republic of Ireland, reporting forms and information can be found at www.hpra.ie and can be reported to HPRA on +353 1 6764971.
Adverse events should also be reported to Galapagos via email to DrugSafety.UK.Ireland@glpg.com or 00800 7878 1345.
Galapagos and the Galapagos logo are registered trademarks of Galapagos NV.
© 2022 Galapagos NV. All rights reserved.
GB-IBD-FIL-202208-00005 |
Date of preparation: October 2023
Contact Us
Galapagos Biotech Ltd
148 Belmont Rd, Uxbridge UB8 1QS
medicalinfo@glpg.com
Galapagos and the Galapagos logo are registered trademarks of Galapagos NV.
© 2022 Galapagos NV. All rights reserved.
GB-IBD-FIL-202208-00005 |
Date of preparation: October 2023
Contact Us
Galapagos Biotech Ltd
148 Belmont Rd, Uxbridge UB8 1QS
medicalinfo@glpg.com
© Copyright 2021 Galapagos NV
This link will take you away from the Galapagos website and you will be re-directed to a non-Galapagos website. Galapagos does not accept liability for sites controlled by third-parties.
*By choosing the "Healthcare Professional" option, you affirm your status as a healthcare professional in the UK and Ireland and acknowledge that you will receive promotional information pertaining to prescription-only medicines.
